Fund · 13F portfolio

Sessa Capital

Sessa Capital · 2026 Q2 13F · period ended Jun 30, 2026 · filed Aug 14, 2026
Reported value
$6.0B
2026 Q2 filing
Stocks held
26
as of Jun 30, 2026
Opened / added
1 / 9
vs previous quarter
Trimmed / exited
2 / 7
vs previous quarter

Holdings · 2026 Q2

TickerCompanyWeightSharesChange
HUMHUMANA INC24.76%3,727,740HELD
WBDWarner Bros. Discovery, Inc.13.45%30,165,805TRIMMED (-5.6%)
KMBKIMBERLY CLARK CORP9.57%5,212,035ADDED (+17.6%)
SHCSotera Health Co8.03%27,050,000ADDED (+17.4%)
PCGPG&E Corp6.91%24,578,101HELD
ALLYAlly Financial Inc.6.52%8,488,098HELD
COFCAPITAL ONE FINANCIAL CORP5.23%1,558,233HELD
ILMNILLUMINA, INC.3.29%1,118,374TRIMMED (-65.9%)
TFXTELEFLEX INC3.24%1,526,228HELD
MICCMagnum Ice Cream Co N.V.2.79%9,589,219ADDED (+100.9%)
GRALGRAIL, Inc.2.33%2,037,518ADDED (+18.5%)
AXTAAxalta Coating Systems Ltd.2.03%3,539,329ADDED (+59.2%)
CPNGCoupang, Inc.1.51%5,190,000HELD
FTREFortrea Holdings Inc.1.34%4,593,550HELD
TNDMTANDEM DIABETES CARE INC1.29%5,100,000ADDED (+7.8%)
ASAASA Gold & Precious Metals Ltd0.91%1,050,000HELD
ROKUROKU, INC0.81%350,000HELD
LXRXLEXICON PHARMACEUTICALS INC0.76%18,960,836ADDED (+5.8%)
MMEDMINIMED GROUP INC0.50%2,000,000HELD
CMCSACOMCAST CORP0.43%1,048,600NEW
SENSSENSEONICS HOLDINGS INC0.42%4,437,532ADDED (+151.3%)
RNAATRIUM THERAPEUTICS INC0.34%1,500,000ADDED (+172.0%)
SABSSAB BIOTHERAPEUTICS INC0.14%2,198,457HELD
BALYBALLY'S CORP0.10%447,799HELD
FLGFLAGSTAR BANK, NATIONAL ASSOCIATION0.01%32,119HELD
BHRBraemar Hotels & Resorts Inc.<0.01%25,951HELD

The weights above sum to 96.7% of the fund’s reported 13F value. Only positions matched to a U.S.-listed ticker are listed; the remainder sits in unmatched or non-equity positions in the filing.

Exited this quarter: APD, COIN, FTAI, OSCR, PFGC, SOLS, USFD.

Source: SEC Form 13F filing for the quarter ended Jun 30, 2026, filed Aug 14, 2026. CIK 0001595849. Change labels compare with the fund’s previous quarterly filing. 13F filings cover long positions only.

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.